Clozapine: an antipsychotic agent in Parkinson's disease? 1989

E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
Belzberg Laboratory of Clinical Neuroscience, Department of Medicine, U.B.C. Health Sciences Centre Hospital, Vancouver, Canada.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
October 1989, Clinical pharmacy,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
August 1991, The New England journal of medicine,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
July 1974, Current therapeutic research, clinical and experimental,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
February 1989, DICP : the annals of pharmacotherapy,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
March 1991, The New England journal of medicine,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
July 1994, The New England journal of medicine,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
January 1975, Psychopharmacology bulletin,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
January 1975, Psychopharmacology bulletin,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
July 1974, Current therapeutic research, clinical and experimental,
E C Wolters, and T A Hurwitz, and R F Peppard, and D B Calne
February 1995, Lancet (London, England),
Copied contents to your clipboard!